112 related articles for article (PubMed ID: 1655518)
21. IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells.
Chen L; Shulman LM; Revel M
J Biol Regul Homeost Agents; 1991; 5(4):125-36. PubMed ID: 1803860
[TBL] [Abstract][Full Text] [Related]
22. Regulation of arachidonic acid metabolism, aromatase activity and growth in human breast cancer cells by interleukin-1beta and phorbol ester: dissociation of a mediatory role for prostaglandin E2 in the autocrine control of cell function.
Hughes R; Timmermans P; Schrey MP
Int J Cancer; 1996 Sep; 67(5):684-9. PubMed ID: 8782659
[TBL] [Abstract][Full Text] [Related]
23. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
[TBL] [Abstract][Full Text] [Related]
24. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells.
Yamashita J; Ogawa M; Nomura K; Matsuo S; Inada K; Yamashita S; Nakashima Y; Saishoji T; Takano S; Fujita S
Cancer Res; 1993 Feb; 53(3):464-7. PubMed ID: 8425178
[TBL] [Abstract][Full Text] [Related]
26. Enhanced motility of KGF-transfected breast cancer cells.
Zang XP; Bullen EC; Manjeshwar S; Jupe ER; Howard EW; Pento JT
Anticancer Res; 2006; 26(2A):961-6. PubMed ID: 16619493
[TBL] [Abstract][Full Text] [Related]
27. Keratinocyte growth factor stimulates the migration and proliferation of breast cancer cells in a culture wounding model.
Nguyen TN; Zang XP; Pento JT
Pharmacol Res; 2002 Aug; 46(2):179-83. PubMed ID: 12220958
[TBL] [Abstract][Full Text] [Related]
28. Induction of IL-2 production, IL-2 receptor expression and proliferation of T3- T-PLL cells by phorbol ester.
Vyth-Dreese FA; De Vries JE
Int J Cancer; 1984 Dec; 34(6):831-8. PubMed ID: 6439651
[TBL] [Abstract][Full Text] [Related]
29. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 protects ductal breast carcinoma cells from MHC-unrestricted cell-mediated cytotoxicity.
Reiter Z; Chen L; Revel M; Rubinstein M
Lymphokine Cytokine Res; 1992 Jun; 11(3):175-81. PubMed ID: 1327193
[TBL] [Abstract][Full Text] [Related]
33. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
Toi M; Bicknell R; Harris AL
Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
[TBL] [Abstract][Full Text] [Related]
35. The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells.
Honma S; Shimodaira K; Shimizu Y; Tsuchiya N; Saito H; Yanaihara T; Okai T
Endocr J; 2002 Jun; 49(3):371-7. PubMed ID: 12201223
[TBL] [Abstract][Full Text] [Related]
36. Synergistic action of phorbol ester and IL-3 in the induction of "connective tissue-type" mast cell proliferation.
Tsuji K; Nakahata T; Takagi M; Kobayashi T; Ishiguro A; Kikuchi T; Naganuma K; Koike K; Miyajima A; Arai K
J Immunol; 1990 Jan; 144(2):678-84. PubMed ID: 2295806
[TBL] [Abstract][Full Text] [Related]
37. Mammary epithelium-induced motility of MCF-7 cells.
Carpenter PM; Nguyen HP
Anticancer Res; 1998; 18(2A):1063-8. PubMed ID: 9615766
[TBL] [Abstract][Full Text] [Related]
38. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
[TBL] [Abstract][Full Text] [Related]
39. alpha 1-Antitrypsin- and anchorage-independent growth of MCF-7 breast cancer cells.
Finlay TH; Tamir S; Kadner SS; Cruz MR; Yavelow J; Levitz M
Endocrinology; 1993 Sep; 133(3):996-1002. PubMed ID: 8365378
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
Gooch JL; Lee AV; Yee D
Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
